Standard definition of loss-to-follow-up for ART patients

October 25, 2011 in HIV & AIDS

A study led by Benjamin Chi of the University of Alabama, Birmingham, USA and colleagues reports on the development of a standard definition for loss-to-follow-up (LTFU) that can be used by HIV antiretroviral programs worldwide. Based on their findings, which are published in this week's PLoS Medicine, the authors recommend that the standard definition for LTFU should be when 180 days or more have elapsed since the patient's last clinic visit.

Patient attrition from antiretroviral therapy (ART) programs is recognized as a threat to the long-term success of such programs worldwide. A standardized method for classifying patients as LTFU is essential in order to be able to compare the performance of different programs, and deduce which factors are responsible for LTFU. In this study, the researchers performed a using data from 111 health facilities across Africa, Asia, and , categorizing patients receiving ART at each facility at a ''status classification'' date as active, or LTFU, using a range of intervals (thresholds) since their last clinic visit.

The authors found that, at a facility level, the best-performing threshold for patient classification ranged from 58 to 383 days (with an average of 150 days), but application of a 180-day threshold to individual facilities only slightly increased misclassifications. Using this 180-day interval, the average LTFU at individual facilities was 19.9%. Though the 180-day threshold produced the fewest patient misclassifications when data from all facilities were pooled, the authors acknowledge that local, national, or regional definitions of LTFU may be more appropriate in certain contexts.

Adopting this standard definition for LTFU should facilitate of monitoring and evaluation of ART programs across the world as well as helping to identify ''best practices'' that are associated with low LTFU rates. The authors note: "Further research is needed to understand individual- and facility-level predictors of LTFU, so that at-risk populations can be identified and appropriate interventions can be evaluated".

They add: "[Standardisation] provides the necessary framework for continued research to improve patient retention, so that the health gains from HIV treatment programs may be maximized and sustained".

More information: Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, et al. (2011) Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. PLoS Med 9(10): e1001111. doi:10.1371/journal.pmed.1001111

Provided by Public Library of Science search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created May 23, 2012 | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (1) | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...